Abstract
Trophic factor treatment has been shown to improve the recovery of brain and spinal cord injury (SCI). In this study, we examined the effects of TSC1 (a combination of insulin-like growth factor 1 and transferrin) 4 and 8 h after SCI at the thoracic segment level (T12) in nestin-GFP transgenic mice. TSC1 treatment for 4 and 8 h increased the number of nestin-expressing cells around the lesion site and prevented Wallerian degeneration. Treatment with TSC1 for 4 h significantly increased heat shock protein (HSP)-32 and HSP-70 expression 1 and 2 mm from lesion site (both, caudal and rostral). Conversely, the number of HSP-32 positive cells decreased after an 8-h TSC1 treatment, although it was still higher than in both, non-treated SCI and intact spinal cord animals. Furthermore, TSC1 increased NG2 expressing cell numbers and preserved most axons intact, facilitating remyelination and repair. These results support our hypothesis that TSC1 is an effective treatment for cell and tissue neuroprotection after SCI. An early intervention is crucial to prevent secondary damage of the injured SC and, in particular, to prevent Wallerian degeneration.
This is a preview of subscription content,
to check access.






Similar content being viewed by others
References
Nelson E, Gertz SD, Rennels ML, Ducker TB, Blaumanis OR (1997) Spinal cord injury. The role of vascular damage in the pathogenesis of central hemorrhagic necrosis. Arch Neurol 34:332–333
Lu J, Ashwell KW, Waite P (2000) Advances in secondary spinal cord injury: role of apoptosis. Spine 25(14):1859–1866
Chang H, Wo JP, Tzeng SF (2002) Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury. J Neuro Res 69:397–405
McDonald JW, Sadowsky C (2002) Spinal-cord injury. Lancet 359:417–425
Beattie MS, Bresnahan JC, Komon J et al (1997) Endogenous repair after spinal cord contusion injuries in the rat. Exp Neurol 148(2):453–463
Grossman SD, Rosenberg LJ, Wrathall JR (2001) Relationship of altered glutamate receptor subunit mRNA expression to acute cell loss after spinal cord contusion. Exp Neurol 168(2):283–289
McGraw J, Hiebert GW, Steeves JD (2001) Modulating astrogliosis after neurotrauma. J Neurosci Res 63(2):109–158
Rosenberg LJ, Zai LJ, Wrathall JR (2005) Chronic alterations in the cellular composition of spinal cord white matter following contusion injury. Glia 49(1):107–120
Sharma HS, Gordh T, Wiklund L, Mohanty S, Sjoquist PO (2005) Spinal cord injury induced heat shock protein expression is reduced by an antioxidant compound H-290/51. An experimental study using light and electron microscopy in the rat. J Neural Trans 113:521–536
Sharma HS (2007) A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury. Ann N Y Acad Sci. 1122:95–111
Yenari MA (2002) Heat shock proteins and neuroprotection. Adv Exp Med Biol 513:281–299
Houenou LJ, Li L, Lei M, Kent CR, Tytell M (1996) Exogenous heat shock cognate protein Hsc 70 prevents axotomy-induced death of spinal sensory neurons. Cell Stress Chaperones 1(3):161–166
Mautes AE, Bergeron M, Sharp FR, Panter SS, Weinzierl M, Guenther K, Noble LJ (2000) Sustained induction of heme oxygenase-1 in the traumatized spinal cord. Exp Neurol 166(2):254–265
Carama NOS, Soares MP (2005) Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic Biol Med 38(4):426–435
Woerly S, Awosika O, Zhao P, Agbo C, Gomez-Pinilla F, de Vellis J, Espinosa-Jeffrey A (2005) Expression of heat shock protein (HSP)-25 and HSP-32 in the rat spinal cord reconstructed with Neurogel. Neurochem Res 30(6–7):721–735
Kitagawa H, Hayashi T, Mitsumoto Y, Koga N, Itoyama Y, Abe K (1998) Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke 29(7):1417–1422
Lee TT, Green BA, Dietrich WD, Yezierski RP (1999) Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat. J Neurotrauma 16(5):347–356
Watabe K, Ohashi T, Sakamoto T, Kawazoe Y, Takeshima T, Oyanagi K, Inoue K, Eto Y, Kim SU (2000) Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor. J Neurosci Res 60:511–519
Sharma HS, Nyberg F, Gordh T, Alm P, Westman J (2000) Neurotrophic factors influence upregulation of constitutive isoform of heme oxygenase and cellular stress response in the spinal cord following trauma. Amino Acids 19:351–361
Ozdinler PH, Macklis JD (2006) IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nature Neurosci 9:1371–1381
Espinosa de los Monteros A, Chiapelli F, Fisher RS, de Vellis J (1988) Transferrin: an early marker of oligodendrocytes in culture. Int J Dev Neurosci 6:167–175
Espinosa de los Monteros A, Kumar S, Zhao P, Huang CJ, Nazarian R, Pan T, Scully S, Chang R, de Vellis J (1999) Transferrin is an essential factor for myelination. Neurochem Res 24(2):235–248
Morgan EH (1996) Molecular iron processing. J Gastroenterol Hepatol 11:1027–1030
Morgan EH, Moos T (2002) Mechanism and developmental changes in iron transport across the blood–brain barrier. Dev Neurosci 24:106–113
Moos T (2002) Brain iron homeostasis. Dan Med Bull 49:279–301
Espinosa-Jeffrey A, Zhao PM, Awosika O, Huang A, Chang R, de Vellis J (2002) Transferrin regulates transcription of the MBP gene and its action synergizes with IGF-1 to enhance myelinogenesis in the md rat. Dev Neurosci 24(2–3):227–241
Espinosa-Jeffrey A, Zhao P, Awosika W, Wu N, Macias F, Cepeda C, Levine M, de Vellis J (2006) Activation, proliferation and commitment of endogenous, stem/progenitor cells to the oligodendrocyte lineage by a combination of neurotrophic factors in a rat model of dysmyelination. Dev Neurosci 28(6):488–498
Paez PM, Garcia CI, Soto EF, Pasquini JM (2006) Apotransferrin decreases the response of oligodendrocyte progenitors to PDGF and inhibits the progression of the cell cycle. Neurochem Inter 49:359–371
Woerly S, Doan VD, Evans-Martin F, Paramore CG, Peduzzi JD (2001) Spinal cord reconstruction using NeuroGel implants and functional recovery after chronic injury. J Neurosci Res 66(6):1187–1197
Woerly S, Doan VD, Sosa N, de Vellis J, Espinosa-Jeffrey A (2004) Prevention of gliotic scar formation by NeuroGel allows partial endogenous repair of transected cat spinal cord. J Neurosci Res 75(2):262–272
Espinosa-Jeffrey A, Oregel K, Wiggins L, Valera R, Bosnoyan K, Agbo C, Awosika O, Zhao P, de Vellis J, Woerly S (2012) Strategies for endogenous spinal cord repair: HPMA hydrogel to recruit migrating endogenous stem cells. Adv Exp Med Biol 760:25–52
Espinosa-Jeffrey A, Barajas S, Arrazola A, Taniguchi A, Zhao P, Bokhoor P, Holley S, Dejarme D, Chu B, Cepeda C, Levine M, Gressens P, Feria-Velasco A, de Vellis J (2013) White matter loss in a mouse model of periventricular leukomalacia is rescued by trophic factors. Brain Sci 3(4):1461–1482
Espinosa-Jeffrey A, Arrazola A, Chu B, Taniguchi A, Barajas S, Bokhoor P, Garcia J, Feria-Velasco A, de Vellis J (2015). J Neurosci Res (accepted)
Yamaguchi M, Saito H, Suzuki M, Mori K (2000) Visualization of neurogenesis in the central nervous system using nestin promoter-GFP transgenic mice. Neuroreport 11:1991–1996
Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV (2004) Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24:2143–2155
Blesch A, Tuszynski MH (2009) Spinal cord injury: plasticity, regeneration and the challenge of translational drug development. Trends Neurosci 32:41–47
Yoon C, Tuszynski MH (2012) Frontiers of spinal cord and spine repair: experimental approaches for repair of spinal cord injury. Adv Exp Med Biol 760:1–15
Kumar S, Biancotti JC, Matalon R, de Vellis J (2009) Lack of aspartoacylase activity disrupts survival differentiation of neural progenitors and oligodendrocytes in a mouse model of Canavan disease. J Neurosci Res 87(15):3415–3427
Espinosa-Jeffrey A, Hitoshi S, Zhao P, Awosika O, Agbo C, Olaniyan E, Garcia J, Valera R, Thomassian A, Chang-Wei R, Yamaguchi M, de Vellis J, Ikenaka K (2010). Functional central nervous system myelin repair in an adult mouse model of demyelination caused by proteolipid protein overexpression. J Neurosci Res 88(8):1682–1694. doi:10.1002/jnr.22334
Richter-Landsberg C, Goldbaum O (2003) Stress proteins in neural cells: functional roles in health and disease. Cell Mol Life Sci 60:337–349
Panahian N, Maines MD (2001) Site of injury-directed induction of heme oxygenase-1 and -2 in experimental spinal cord injury: differential functions in neuronal defense mechanisms? J Neurochem 76:539–554
Liu Y, Tachibana T, Dai Y, Kondo E, Fukuoka T, Yamanaka H, Noguchi K (2002) Heme oxygenase-1 expression after spinal cord injury: the induction in activated neutrophils. J Neurotrauma 19:479–490
Goldbaum O, Richter-Landsberg C (2001) Stress proteins in oligodendrocytes: differential effects of heat shock and oxidative stress. J Neurochem 78(6):1233–1242
Cizkova D, Lukacova N, Marsala M, Kafka J, Lukac I, Jergova S, Cizek M, Marsala J (2005) Experimental cauda equina compression induces HSP70 synthesis in dog. Physiol Res 54:349–356
Carmel JB, Galate A, Soteropoulos P, Tolias P, Recce M, Young W, Hart RP (2001) Spinal cord injury: plasticity, regeneration and the challenge of translational drug development. Physiol Genom 7:201–213
Ulrich HF (1996) Molecular chaperones in cellular protein folding. Nature 381:571–580
Michels AA, Kanon B, Konings AWT, Ohtsuka K, Bensaude O, Kampinga HH (1997) Hsp70 and Hsp40 chaperone activities in the cytoplasm and the nucleus of mammalian cells. J Giol Chem 272:33283–33289
Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255(5052):1707–1710
Steinert PM, Chou YH, Prahlad V, Parry DA, Marekov LN, Wu KC, Jang SI, Goldman RD (1999) A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein. Limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-internexin. J Biol Chem 274(14):9881–9890
Tohyama T, Lee VM, Rorke LB, Marvin M, McKay RD, Trojanowski JQ (1992) Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 66(3):303–313
Suzuki S, Namiki J, Shibata S, Mastuzaki Y, Okano H (2010) The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature. J Histochem Cytochem 58(8):721–730
Fukuda S, Kato F, Tozuka Y, Yamaguchi M, Miyamoto Y, Hisatsune T (2003) Two distinct subpopulations of nestin-positive cells in adult mouse dentate gyrus. J Neurosci 23(28):9357–9366
Palmer TD, Willhoite AR, Gage FH (2000) Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425:479–494
Shin YJ, Kim HL, Park JM, Cho JM, Kim SY, Lee MY (2013) Characterization of nestin expression and vessel association in the ischemic core following focal cerebral ischemia in rats. Cell Tissue Res 351(3):383–395
Mothe AJ, Tator CH (2005) Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat. Neuroscience 131:177–187
Fernandez AM, Torres-Aleman I (2012). The many faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci 13(4):225–239. doi:10.1038/nrn3209
McMorris FA, Duboi-Dalcq M (1988) Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J Neurosci Res 21:199–209
McMorris FA, McKinnon RD (1996) Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease. Brain Pathol 6:313–329
Werner H, Woloschak M, Adamo M, She-Orr Z, Roberts CT, LeRoith D (1989) Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 86:7451–7455
Madathil SK, Evans HN, Saatman KE (2010) Temporal and regional changes in IGF-1/IGF-1R signaling in the mouse brain after traumatic brain injury. J Neurotra 27:95–107
Anderson MF, Aberg MA, Nilsson M, Eriksson PS (2000) Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res Dev Brain Res 134:115–122
Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD, Flannery R, Jaenisch R, Sur M (2009) Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci USA 106:2029–2034
Dubois-Dalcq Murray K (2000) Why are growth factors important in oligodendrocyte physiology? Pathol Biol (Paris) 48:80–86
Hsieh J, Aimone JB, Kaspar BK, Kuwabara T, Kakashima K, Gage FH (2004) IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. J Cell Biol 164:111–122
Espinosa de los Monteros A, Pena LA, de Vellis J (1989) Does transferrin have a special role in the nervous system? J Neurosci Res 24:125–136
Aizenman Y, Weichsel ME, de Vellis J (1986) Changes in insulin and transferrin requirements of pure brain neuronal cultures during embryonic development. Proc Natl Acad Sci USA 83:2263–2266
Saneto RP, de Vellis J (1985) Characterization of cultured rat oligodendrocytes proliferating in a serum-free, chemically defined médium. Proc Natl Acad Sci USA 82:3509–3513
Espinosa de los Monteros A, Zhang M, Gordon MN, Kumar S, Scully S, de Vellis J (1990) The myelin-deficient rat mutant: partial recovery of oligodendrocyte maturation in vitro. Dev Neurosci 12:326–339
Barres BA, Jacobson MD, Schmid R, Sendtner M, Raff MC (1993) Does oligodendrocyte survival depend on axons? Curr Biol 3:489–497
Guan J, Bennet L, Gluckman PD, Gunn AJ (2003) Insulin-like growth factor-1 and post-ischemic brain injury. Prog Neurobio 70:443–462
Aquino JB, Musolino PL, Coronel MF, Villar MJ, Setton-Avruj CP (2006) Nerve degeneration is prevented by a single intraneural apotransferrrin injection into colchicines-injured sciatic nerves in the rat. Brain Res 30:80–91
Nishiyama A, Komitova M, Suzuki R, Zhu X (2009) Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 10:9–22
Maus F, Sakry D, Binamé F, Karram K, Rajalingam K, Watts C, Heywood R, Krüger R, Stegmüller J, Werner HB, Nave KA, Krämer-Albers EM, Trotter J (2015) The NG2 proteoglycan protects oligodendrocyte precursor cells against oxidative stress via interaction with OMI/HtrA2. PLoS ONE 10:e0137311
Yang Z, Suzuki R, Daniels SB, Brunquell CB, Sala CJ, Nishiyama A (2006) NG2 glial cells provide a favorable substrate for growing axons. J Neurosci 14:3829–3839
Bareyre FM, Schwab ME (2003) Inflammation, degeneration and regeneration in the injury spinal cord: insights from DNA microarrays. Trend Neurosci 26:555–563
Totoiu MO, Keirstead HS (2005) Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 486:373–383
McTigue D, Wei P, Stokes BT (2001) Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J Neurosci 21:3392–3400
Sekhon LH, Fehlings MG (2001) Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26:S2–S12
Aguirre A, Gallo V (2007) Reduced EGFR signaling in progenitor cells of the adult subventricular zone attenuates oligodendrogenesis after demyelination. Neuron Glia Biol 3:209–220
Espinosa de los Monteros A, Zhao PM, de Vellis J (2001) In vitro injury model for oligodendrocytes: development, injury, and recovery. Micro Res Tech. 52:719–730
Krityakiarana W, Espinosa-Jeffrey A, Ghiani C, Zhao M, Topaldjikian N, Gomez-Pinilla F, Yamaguchi M, Kotchabhakdi N, de Vellis J (2010) Voluntary exercise increases oligodendro-genesis in spinal cord. Int J Neurosci 120(4):280–290
Katic M, Kahn CR (2005) The role of insulin and IGF-1 signaling in longevity. Cell Mol Life Sci 62(3):320–343
Klausner RD, Ashwell G, van Renswoude J, Harford JB, Bridges KR (1983) Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc Natl Acad Sci USA 80:2263–2266
Klausner RD, Van Renswoude J, Ashwell G, Kempf C, Schechter AN, Dean A, Bridges KR (1983) Receptor-mediated endocytosis of transferrin in K562 cells. J Biol Chem 258:4715–4724
Pantopoulos K, Hentze MW (1995) Rapid responses to oxidative stress mediated by iron regulatory protein. Embo J 14:2917–2924
Hill JM, Switzer RC 3rd (1984) The regional distribution and cellular localization of iron in the rat brain. Neuroscience 11(3):595–603
Takeda A, Takatsuka K, Connor JR, Oku N (2002) Abnormal iron delivery to the bone marrow in neonatal hypotransferrinemic mice. Biometals 15:33–36
Zaleska MM, Floyd R (1985) Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron. Neurochem Res 10:397
Double KL, Gerlach M, Youdim MB, Riederer P (2000) Impaired iron homeostasis in Parkinson’s disease. J Neural Transm Suppl 60:37–58
Pinero DJ, Hu J, Connor JR (2000) Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer’s diseased brains. Cell Mol Biol (Noisy-le-grand) 46:761–776
Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PM (1995) Transferrin and iron in normal, Alzheimer’s disease, and Parkinson’s disease brain regions. J Neurochem 65:710–716
Clos J, Westwood JT, Becker PB, Wilson S, Lambert K, Wu C (1990) Molecular cloning and expression of a hexameric Drosophila heat shock factor subject to negative regulation. Cell 63(5):1085–1097
Guertin MJ, Lis JT (2010) Chromatin landscape dictates HSF binding to target DNA elements. PLoS Genet 6(9):e1001114
Guertin MJ, Petesch SJ, Zobeck KL, Min IM, Lis JT (2010) Drosophila heat shock system as ageneral model to investigate transcriptional regulation. Cold Spring Harb Symp Quant Biol 75:1–9
Sorger PL (1991) Heat shock factor and the heat shock response. Cell 65(3):363–366
Morimoto RI (1993) Cells in stress: transcriptional activation of heat shock genes. Science 259(5100):1409–1410
Rabindran SK, Giorgi G, Clos J, Wu C (1991) Molecular cloning and expression of a human heat shock factor, HSF1. Proc Natl Acad Sci USA 88(16):6906–6910
Prahlad V, Morimoto RI (2008) Intergrating the stress response: lessons for neurodegenerative diseases from C. elegans. Trends Cell Biol 19(2):52–61
Guettouche T, Boellmann F, Lane WS, Richard Voellmy (2005) Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress. BMC Biochem 6:4
Salamanca HH, Fuda N, Shi H, Lis JT (2011) An RNA aptamer perturbs heat shock transcription factor activity in drosophila melanogaster. Nucleic Acids Res 39(15):6729–6740
Salamanca HH, Antonyak MA, Cerione RA, Shi H, Lis JT (2014) Inhibiting heat shock factor 1 in human cancer cells with a potent RNA aptamer. PLoS One 9(5):e96330
Acknowledgments
We are grateful to Dr. Michael Sofroniew and his team for teaching us the spinal cord injury technique. We also thank Dr. Nuanchan Jutapakdeegul for their contribution to improve the quality of the article, Dorwin Birt for help with computer support and figure composites. This work was supported by NIH Grants: HD004612, HD006576 and scholarship from the University Development Program (UDP), Thailand.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
There are various signaling pathways involved in IGF-1 normal activity in the CNS. Ligand binding to IGF-1 receptors (IGF1Rs) triggers receptor autophosphorylation and association with docking proteins (not shown; for review see [82]. Upon cell injury (center of diagram) apoptosome formation is triggered by the release of cytochrome c from damaged mitochondria in response to either intrinsic or extrinsic cell death stimuli. The cytochrome binds to ATP-dependent proteolysis factor 1(Apf-1) monomeres which then create APF heptameres or heptamere apoptosomes. Recruitment of pro-caspase-9, either in the apoptosome or binding directly to Apf1, activates caspase 9, cleaves pro-caspase-3 and activates it. Caspase-3 breaks down cellular components for their recycling. Based on the reports from Wood and collaborators one can infer that in our experimental paradigm exogenous IGF-1 contained in TSC1 may prevent mitochondrial damage and cytochrome release blocking the caspase chain of events that lead to apoptosis (see text for details). The amount of iron (left part of the diagram) in cells is controlled by the cell surface transferrin receptor (TfR)-mediated uptake of iron as transferrin-iron. [83] TfR synthesis is regulated by interaction of the iron regulatory protein (IRP) with the iron-responsive element (IRE) present on the 3′ untranslated region of TfR mRNA. IRPs serve as sensors of cellular iron. [83–85]. The cellular oxidative damage caused by reactive oxygen species and reactive nitrogen species is critically controlled by cellular iron homeostasis [85]. Exposure to H2O2, enhances the expression of TfR mRNA, where TfR appears to be the link between oxidative stress and TfR-mediated iron uptake. Transferrin (Tf) (left part of the diagram) is the iron carrier glycoprotein for all normal cells of mammalians. In circulation, it is saturated to around 30 % in adults. Thus, allowing for the chelation of iron radicals released after cell injury. In the CNS, Tf is synthesized by OLs and choroid plexus. Iron (Fe) is found in OLs and myelin in high density and both iron and Tf are required for myelin production [22, 85, 86]. As discussed by [87] and other authors, excess and/of free iron can be cytotoxic, by catalyzing the production of hydoxyl radicals from hydrogen peroxide [88]. Increased iron concentrations in the brain have been shown in neurodegenerative diseases, e.g. Alzheimer’s disease and Parkinson’s disease [89, 90] where oxidative stress has been proposed as a pathogenic mechanism of neurodegeneration. Conversely, brain Tf levels decrease with age and the decrease is dramatic when Alzheimer’s and Parkinson’s disease are superimposed on the aging process [91]. This stoichiometry of the iron related proteins Tf, ferritin and transferrin receptor (TFR) is essential to maintain CNS function. Upon OLPs and or myelin breakdown free iron is released. In our experimental model, Tf may act as a transient chelator while “Ferritin”, the iron storage protein, is synthesized (circle with red dots) helping prevent oxidative stress and lipid peroxidation. Heat shock factors (HSF) are transcriptional activators of heat shock HSP (P) genes [92]. These activators bind specifically to Heat Shock sequence Elements (HSE) throughout the genome [93–98]. The Heat shock factor (HSF/HSF1) mediates the stress-induced expression of heat shock or stress proteins (HSPs). HSF/HSF1 is inactive in unstressed cells and it is activated during stress. Activation includes its hyperphosphorylation. Twelve Serine residues are phosphorylated in heat-activated HSF1 from which phosphorylation of HSF1 residue Ser326 plays a critical role in the induction of the factor’s transcriptional competence by heat stress and chemical stress. The functional role of other newly identified phosphor Ser residues remains unknown [99]. The Heat Shock sequence Element is highly conserved from yeast to humans. Heat shock factors (HSF) are transcriptional activators of heat shock genes. These activators bind specifically to Heat Shock sequence Elements (HSE) throughout the genome [93]. Although not shown in the diagram, eat shock proteins bind to the misfolded proteins and dissociate from HSF-1. This allows HSF1 to form trimers and translocate to the cell nucleus and activate transcription [7]. Its function is not only critical to overcome the proteotoxic effects of thermal stress, but also needed for proper animal development and the overall survival of cancer cells [100, 101]. It is worth mentioning that we have previously shown a synergistic effects of TSC1 as a neuroprotective agent. In the present work, we showed that a single dose of TSC1 was necessary and sufficient to increase the number of HSP-32-expressing cells most likely by HSF phosphorylation, hence promoting mitochondria homeostasis and energy management (Fig. 8).
Rights and permissions
About this article
Cite this article
Krityakiarana, W., Zhao, P.M., Nguyen, K. et al. Proof-of Concept that an Acute Trophic Factors Intervention After Spinal Cord Injury Provides an Adequate Niche for Neuroprotection, Recruitment of Nestin-Expressing Progenitors and Regeneration. Neurochem Res 41, 431–449 (2016). https://doi.org/10.1007/s11064-016-1850-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-016-1850-z